tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CMPS Stock Latest News

Psychedelic: Clearmind completes clinical site initiations for AUD trial
The FlyPsychedelic: Clearmind completes clinical site initiations for AUD trial
3d ago
CMND
CMPS
Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial
PremiumThe Fly
Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial
6d ago
CMPS
COMPASS Pathways Amends Executive Employment Agreements
PremiumCompany Announcements
COMPASS Pathways Amends Executive Employment Agreements
12d ago
8K
CMPS
Psychedelic: Exclusive talk with retreat provider ONE Retreats
PremiumThe Fly
Psychedelic: Exclusive talk with retreat provider ONE Retreats
1M ago
ATAI
CMND
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
PremiumThe Fly
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
1M ago
ATAI
CMND
Psychedelic: atai Life Sciences, NRx report quarterly results
PremiumThe FlyPsychedelic: atai Life Sciences, NRx report quarterly results
1M ago
ATAI
CMND
Compass Pathways announces published study on psilocybin in depression
Premium
The Fly
Compass Pathways announces published study on psilocybin in depression
1M ago
CMPS
Psychedelic: MindMed reports Q4 earnings results
Premium
The Fly
Psychedelic: MindMed reports Q4 earnings results
2M ago
ATAI
CMND
Compass one of the most compelling stories in neuropsych, says H.C. Wainwright
PremiumThe Fly
Compass one of the most compelling stories in neuropsych, says H.C. Wainwright
2M ago
CMPS
COMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry with COMP360 Advancements
PremiumRatings
COMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry with COMP360 Advancements
2M ago
CMPS
Optimistic Buy Rating for COMPASS Pathways: Strategic Trials and Strong Financial Position Bolster Confidence in COMP360’s Potential
PremiumRatings
Optimistic Buy Rating for COMPASS Pathways: Strategic Trials and Strong Financial Position Bolster Confidence in COMP360’s Potential
2M ago
CMPS
Buy Rating for COMPASS Pathways: Promising Phase 3 Trial Progress and Strong Financial Position
PremiumRatings
Buy Rating for COMPASS Pathways: Promising Phase 3 Trial Progress and Strong Financial Position
2M ago
CMPS
Compass Pathways price target lowered to $15 from $23 at Canaccord
PremiumThe FlyCompass Pathways price target lowered to $15 from $23 at Canaccord
2M ago
CMPS
Compass Pathways Reports 2024 Financial Results and Progress
Premium
Company Announcements
Compass Pathways Reports 2024 Financial Results and Progress
2M ago
CMPS
COMPASS Pathways’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
COMPASS Pathways’ Earnings Call: Progress Amid Challenges
2M ago
CMPS
Psychedelic: GH Research, Compass Pathways report earnings results
PremiumThe Fly
Psychedelic: GH Research, Compass Pathways report earnings results
2M ago
ATAI
CMND
Compass Pathways reports Q4 EPS (63c), consensus (62c)
PremiumThe Fly
Compass Pathways reports Q4 EPS (63c), consensus (62c)
2M ago
CMPS
Compass Pathways sees FY25 net cash use $120M-$145M
PremiumThe Fly
Compass Pathways sees FY25 net cash use $120M-$145M
2M ago
CMPS
Positive Outlook for COMPASS Pathways Amid Psychedelic Acceptance and Strategic Investment Opportunity
PremiumRatings
Positive Outlook for COMPASS Pathways Amid Psychedelic Acceptance and Strategic Investment Opportunity
2M ago
CMPS
Compass Pathways initiated with a Buy at Stifel
PremiumThe FlyCompass Pathways initiated with a Buy at Stifel
2M ago
CMPS
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
2M ago
ATAI
CMND
Compass Pathways price target lowered to $45 from $60 at H.C. Wainwright
Premium
The Fly
Compass Pathways price target lowered to $45 from $60 at H.C. Wainwright
2M ago
CMPS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >